Sanofi Falls, M&G Rises, Gap Down
Stock Movers
00:00
Sanofi's Disappointing Drug Trial Causes Market Downturn
This chapter explores the recent downturn in Sanofi's shares, which dropped by 7% following disappointing results from a critical drug trial for lung conditions. Analysts highlight the implications of these outcomes on the drug's market value and the broader European stock fluctuations.
Transcript
Play full episode
